Threshold Pharmaceuticals (THLD) gapped open higher Monday morning and is now up 0.76 at $3.75 in early trade.
Threshold Pharmaceuticals is extending the sharp increase posted on Friday, after the company announced a global agreement with Merck KGaA to co-develop and commercialize TH-302. The stock has set a new high for the year Monday morning, on above average trading volume.
For comments and feedback: editorial@rttnews.com